標(biāo)題: Titlebook: Virus Entry Inhibitors; Stopping the Enemy a Shibo Jiang,Lu Lu Book 2022 The Editor(s) (if applicable) and The Author(s), under exclusive l [打印本頁(yè)] 作者: ACRO 時(shí)間: 2025-3-21 19:30
書目名稱Virus Entry Inhibitors影響因子(影響力)
作者: engender 時(shí)間: 2025-3-21 22:57 作者: 笨重 時(shí)間: 2025-3-22 01:52
https://doi.org/10.1007/978-981-16-8702-0Virus; Virus entry; Virus entry inhibitor; Antiviral Therapy; HIV; HBV; HCV; Ebola virus; Influenza virus作者: 為寵愛 時(shí)間: 2025-3-22 06:41 作者: bacteria 時(shí)間: 2025-3-22 10:39 作者: 簡(jiǎn)略 時(shí)間: 2025-3-22 15:35
Virus Entry Inhibitors978-981-16-8702-0Series ISSN 0065-2598 Series E-ISSN 2214-8019 作者: EWE 時(shí)間: 2025-3-22 18:49
Jing Pu,Qian Wang,Shibo Jianghier unersch?pfliche Zahl an Rechtsinhalten, sondern auch eine, wenngleich viel beschr?nktere Zahl an Rechtsformen, genauer Rechtssatzformen. Es hat nicht blo? jeder einzelne Rechtssatz einen von jedem anderen Rechtssatz verschiedenen Inhalt, sondern auch eine Gruppe von Rechtss?tzen eine von den an作者: Intercept 時(shí)間: 2025-3-22 23:19
Huan Wang,Chao Wangs Münchner Malers Franz von Stuck erneut zur Diskussion gestellt worden. Aus privater Initiative und mit F?rderung durch die Stadt München ist das Doppelhaus der Stuck-Villa an der Prinzregentenstra?e aus Kriegsbesch?digung und Verfall neu erstanden. Prunk- und Privatr?ume Stucks dienen nunmehr als 作者: 使聲音降低 時(shí)間: 2025-3-23 05:20 作者: 象形文字 時(shí)間: 2025-3-23 07:55 作者: glans-penis 時(shí)間: 2025-3-23 11:53
Yang Yang,Youhua Xief petroleum companies and how they contributed to the culture of the work place. Some oil companies formed women’s groups for education and culture building for female employees across the company. An example is “Distafforum” that was founded at Mobile. “The Distaffforum,” which was formerly “The Wo作者: 蘑菇 時(shí)間: 2025-3-23 17:19
Xi-Jing Qian,Zhong-Tian Qien, kompatiblen Gruppenstruktur. Hier bezieht sich Kompatibilit?t auf die Tatsache, dass die Gruppenoperationen glatt sind (ein anderer Standpunkt ist, eine Lie-Gruppe als eine Gruppe mit einer zus?tzlichen Struktur von Mannigfaltigkeit zu betrachten…). Der Leser kann die Matrixgruppe . von nicht-si作者: insincerity 時(shí)間: 2025-3-23 22:00
Yun Zhuical and pathological features of primary open-angle glaucoma (POAG), and therefore mouse models of GC-induced glaucoma are utilized to study pathophysiology of glaucoma. We have recently demonstrated that weekly periocular injections of dexamethasone-21-acetate (Dex-Ac) lead to robust and significa作者: insipid 時(shí)間: 2025-3-23 22:13 作者: 商業(yè)上 時(shí)間: 2025-3-24 02:52
Peptide-Based Dual HIV and Coronavirus Entry Inhibitors,cific to the virus that is developed for. In this review, we focus on peptide-based entry dual inhibitors that block fusion process not only of HIV but also coronaviruses through interrupting their fusogenic six-helical bundle core and which hopefully will help to gain insight into the α-helical sec作者: 舔食 時(shí)間: 2025-3-24 08:09
Broad-spectrum Respiratory Virus Entry Inhibitors,als. In this chapter, we mainly focus on discussing the risks of respiratory viruses, the challenge of finding broad-spectrum antivirals, the entry processes of respiratory viruses, the current studies on broad-spectrum entry inhibitors for respiratory viruses, and the directions for discovering bro作者: 完全 時(shí)間: 2025-3-24 13:23
Flavivirus Entry Inhibitors,y inhibitors with well-defined target and antiviral activity. We hope that our review will provide a theoretical basis for flavivirus treatment and drug research and help to accelerate the clinical application of flavivirus entry inhibitors.作者: 船員 時(shí)間: 2025-3-24 16:40
Entry Inhibitors of Hepatitis C Virus,ts for antiviral therapy, eliminating viral infection at the very beginning. Therefore, entry inhibitors can be supplemented into the future treatment regimens to optimize and widen the prevention and therapeutics of HCV infection. This chapter introduces the basic HCV entry processes and summarizes作者: 剛毅 時(shí)間: 2025-3-24 20:47
Jing Pu,Qian Wang,Shibo Jianguprema lex“ zum Ausdruck kommt, ersch?pft sich doch nicht in diesem inhaltsarmen Rechtssatz, vielmehr ist dieser Rechtssatz — die typische Verfassung des absoluten Staates — der Ursprung einer verschieden gro?en Zahl anderer Rechtss?tze, die den Untertanen ein vom Herrscher inhaltlich n?her bestimmt作者: Accord 時(shí)間: 2025-3-25 00:50 作者: 歌曲 時(shí)間: 2025-3-25 06:50 作者: 奴才 時(shí)間: 2025-3-25 08:53
Yufeng Yu,Lulu Si,Yu Mengthe chapter is based on a historical qualitative analysis of Girmitiya peasants in Suriname, a former plantation economy on the north-eastern coast of South America. The analysis deals specifically with homemaking in an agrarian context as it was the peasants who established the ethnic community rat作者: 六邊形 時(shí)間: 2025-3-25 13:40 作者: Phagocytes 時(shí)間: 2025-3-25 16:34 作者: 沒(méi)有希望 時(shí)間: 2025-3-25 21:05 作者: GET 時(shí)間: 2025-3-26 04:07
Tao Wang,John F. Kadow,Nicholas A. Meanwell,Mark Krystal作者: 初次登臺(tái) 時(shí)間: 2025-3-26 04:55
Mirja Harms,Manuel Hayn,Fabian Zech,Frank Kirchhoff,Jan Münch作者: 虛情假意 時(shí)間: 2025-3-26 09:49
Virus Entry Inhibitors: Past, Present, and Future,mall-molecule-, and protein-based entry inhibitors have been identified and approved for viral diseases. Here we reviewed the development of virus entry inhibitors and the advantages and disadvantages of peptide-, small-molecule-, and protein-based entry inhibitors, herein summarizing the future tre作者: 物種起源 時(shí)間: 2025-3-26 13:04 作者: 四溢 時(shí)間: 2025-3-26 18:17
Small-Molecule HIV Entry Inhibitors Targeting gp120 and gp41,entry into host cells is mediated by the envelope glycoprotein (Env) trimer, which is composed of three gp120 exterior glycoproteins and three gp41 transmembrane glycoproteins. Hence, the development of novel inhibitors targeting these two glycoproteins could hold the key to early inhibition of HIV-作者: Gleason-score 時(shí)間: 2025-3-27 00:45 作者: Demonstrate 時(shí)間: 2025-3-27 03:57
Endogenous Peptide Inhibitors of HIV Entry,SDF-1/CXCL12 inhibits specific viral strains. The knowledge that RANTES, MlP-1α, and MlP-1β specifically inhibit other primary HIV-1 strains allowed the rapid discovery of CCR5 as second major viral coreceptor and explained why individuals with deletions in CCR5 are protected against sexual HIV-1 tr作者: 形容詞 時(shí)間: 2025-3-27 09:13 作者: synovitis 時(shí)間: 2025-3-27 12:40 作者: AV-node 時(shí)間: 2025-3-27 14:40 作者: 帶來(lái)墨水 時(shí)間: 2025-3-27 21:40
Broad-spectrum Respiratory Virus Entry Inhibitors,ile more than 260 viruses are known to infect humans, only a small minority of these viral diseases are treatable by clinically approved antiviral drugs. Apart from these identified viruses, new emerging viruses and drug-resistant viruses are also important challenges to our public health and health作者: 暫時(shí)過(guò)來(lái) 時(shí)間: 2025-3-27 22:46
Ebola Virus Entry Inhibitors,ugh two monoclonal antibody (mAb) drugs have recently received approval in the USA, additional therapeutics are still needed to combat potential outbreaks of resistance variants and other closely related ebola viruses. In this chapter, we describe the current understanding of the EBOV entry process 作者: visceral-fat 時(shí)間: 2025-3-28 03:04 作者: Agronomy 時(shí)間: 2025-3-28 07:45
Entry Inhibitors of Hepatitis B and D Viruses, the major cause of chronic hepatitis, liver failure, cirrhosis, and hepatocellular carcinoma (HCC). In nature, HBV and HDV have a narrow host range and highly hepatotropic, only infecting the hepatocytes of humans and a few primates. The elucidation of cell entry mechanism by HBV has made great pro作者: Employee 時(shí)間: 2025-3-28 13:13 作者: maculated 時(shí)間: 2025-3-28 16:50
Human Papillomavirus (HPV) Entry Inhibitors,eveloping new diagnostic and prognostic biomarkers and designing more effective targeted therapeutics and treatment strategies remains urgent. Numerous efforts have been made to design new drugs and vaccines to treat HPV infections. Due to the special HPV infection pathway, entry inhibitors to block作者: 緊張過(guò)度 時(shí)間: 2025-3-28 21:22 作者: Onerous 時(shí)間: 2025-3-29 00:42 作者: 事物的方面 時(shí)間: 2025-3-29 04:59
Endogenous Peptide Inhibitors of HIV Entry,ents and beyond. Finally, we provide examples for other endogenous peptides that may contribute to our innate immune defense against HIV-1 and other viral pathogens and offer prospects for preventive or therapeutic development.作者: AUGER 時(shí)間: 2025-3-29 08:17
Virus Entry Inhibitors: Past, Present, and Future,e prophylaxis, microbicides, and therapeutics. This chapter, as well as this book, provides more information on the development and modification of peptide-, small-molecule-, and protein-based virus entry inhibitors.作者: Chivalrous 時(shí)間: 2025-3-29 13:03 作者: Incorporate 時(shí)間: 2025-3-29 17:37
Coronavirus Entry Inhibitors,ses in viral entry, such as receptor binding, proteolytic activation of spike protein, or virus-cell membrane fusion. Coronavirus entry inhibitors, alone or in combination with other drugs, play important roles in the treatment of coronavirus diseases. Thus, we summarize and discuss the development of coronavirus entry inhibitors in this chapter.作者: FAZE 時(shí)間: 2025-3-29 19:49
Influenza Virus Entry inhibitors,trials, including small molecule, natural product, peptide-based entry inhibitors, and other types of entry inhibitors, herein discussing some open questions. Assay methods of influenza virus entry inhibitors are also outlined.作者: Decimate 時(shí)間: 2025-3-30 02:32 作者: 開花期女 時(shí)間: 2025-3-30 04:48 作者: 填滿 時(shí)間: 2025-3-30 10:41 作者: Chronological 時(shí)間: 2025-3-30 15:20
Entry Inhibitors of Hepatitis B and D Viruses,gress in recent years, which strongly promotes the establishment of new HBV infection models and the development of viral entry inhibitors. The study of HBV entry inhibitors has culminated in the first direct antiviral treatment for HDV. This review provides a concise introduction on the progress of HBV/HDV entry inhibitors in the recent years.作者: 流動(dòng)性 時(shí)間: 2025-3-30 18:55
0065-2598 l drugs for treatment and prevention of viral infection. It includes entry inhibitors of HIV,HeV, NiV, RSV, EBOV, HCoV, HBV, HCV, HDV, HPV, flavivirus and influenza virus, so on. This book aims at providing an updated knowledge on virus entry inhibitors....978-981-16-8704-4978-981-16-8702-0Series ISSN 0065-2598 Series E-ISSN 2214-8019
